Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Hemoglobin
    November 2022
  1. WEN YJ, Yu QX, Jiang F, Li DZ, et al
    Identification of a Novel Mutation in the 3' Untranslated Region of the beta-Globin Gene (HBB:c.*132C>G) in a Chinese Family.
    Hemoglobin. 2022;46:347-350.
    >> Share

  2. GIAMBONA A, Leto F, Cassara F, Tartaglia V, et al
    Celocentesis for Early Prenatal Diagnosis in Couples at-Risk for beta-Thalassemia and Sicilian (deltabeta)(0)-Thalassemia.
    Hemoglobin. 2022;46:297-302.
    >> Share

  3. ELEFTHERIOU A, Antoniou E, Darba J, Ascanio M, et al
    Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model.
    Hemoglobin. 2022;46:308-311.
    >> Share

  4. WU SM, Huang SR, Li C, Chen GL, et al
    Severe Hb H Disease Caused by Hb Zurich-Albisrieden (HBA1: c.178G>C): Another Case Report.
    Hemoglobin. 2022;46:341-343.
    >> Share

  5. SUALI L, Mohammad Salih FA, Ibrahim MY, Jeffree MSB, et al
    Genotype-Phenotype Study of beta-Thalassemia Patients in Sabah.
    Hemoglobin. 2022;46:317-324.
    >> Share

  6. ASMARIAN N, Kamalipour A, Hosseini-Bensenjan M, Karimi M, et al
    Prediction of Heart and Liver Iron Overload in beta-Thalassemia Major Patients Using Machine Learning Methods.
    Hemoglobin. 2022;46:303-307.
    >> Share

  7. GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al
    A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease.
    Hemoglobin. 2022;46:338-340.
    Lys; HBB: c.22G>A] and Hb H Disease.&body=GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al. A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease. Hemoglobin. 2022;46:338-340. https://www.ncbi.nlm.nih.gov/m/pubmed/36691989" ALT="Email" TITLE="Email"> --> >> Share

  8. LONG J, Gong F, Sun L, Lai G, et al
    Identification of Three Families Carrying Hb Anti-Lepore Hong Kong Variant in Guangxi, China, and Analysis of Their Hematological Data.
    Hemoglobin. 2022;46:325-329.
    >> Share

    September 2022
  9. YIN ZZ, Yao J, Wei FX, Chen CY, et al
    Targeted Next-Generation Sequencing Reveals a Large Novel beta-Thalassemia Deletion that Removes the Entire HBB Gene.
    Hemoglobin. 2022;46:290-295.
    >> Share

  10. VACHHANI NA, Vekariya DJ, Colah RB, Kashiyani HN, et al
    Spectrum of beta-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program.
    Hemoglobin. 2022;46:285-289.
    >> Share

  11. WANG K, Yi T, Wu WT, Lu J, et al
    Investigation of the Distribution of Thalassemia in Children in Jiangxi Province, the People's Republic of China.
    Hemoglobin. 2022;46:272-276.
    >> Share

    August 2022
  12. AMARASINGHA AADS, Silva HJRL, Perera PS, Premawardhena AP, et al
    Anemia in Sri Lanka: A Literature Review.
    Hemoglobin. 2022 Aug 24:1-11. doi: 10.1080/03630269.2022.2096460.
    >> Share

    July 2022
  13. BAO XQ, Wang JC, Qin DQ, Yao CZ, et al
    A Novel 5 kb Deletion in the beta-Globin Gene Cluster Identified in a Chinese Patient.
    Hemoglobin. 2022;46:245-248.
    >> Share

  14. WARANG PP, Shinde NS, Umare VD, Deshmukh PV, et al
    Role of Oxidative Stress and the Protective Effect of Fermented Papaya Preparation in Sickle Cell Disease.
    Hemoglobin. 2022;46:260-264.
    >> Share

  15. FARMAKIS D, Angastiniotis M, El Ghoul MM, Cannon L, et al
    Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation.
    Hemoglobin. 2022;46:225-232.
    >> Share

  16. LAM TT, Nguyen DT, Le QT, Nguyen DA, et al
    Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve alpha- and beta-Thalassemia Carrier Screening in Pregnant Women in Vietnam.
    Hemoglobin. 2022;46:233-239.
    >> Share

  17. LOCKE M, Reddy PS, Badawy SM
    Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review.
    Hemoglobin. 2022;46:201-213.
    >> Share

  18. LIN XM, Jiang F, Li J, Li DZ, et al
    Dominantly Inherited beta-Thalassemia Caused by a Single Nucleotide Deletion in Exon 3 of the beta-Globin Gene: Hb Xiangyang (HBB: c.393delT).
    Hemoglobin. 2022;46:253-255.
    >> Share

  19. SEN A, Sen A, Dolai TK
    Diagnostic Dilemma of Hemoglobinopathies Using High Performance Liquid Chromatography Alone: A Case Report from a Resource-Constrained Setting.
    Hemoglobin. 2022;46:256-259.
    >> Share

  20. LIAO J, Li Q, Ling LQ, Liu CN, et al
    A Triple-Heterozygous beta-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel beta(0) Mutation [an IVS-II-654 (C>T) mutation with a Hb Zurich-Langstrasse (HBB: c.151A>T) mutation in cis].
    Hemoglobin. 2022;46:249-252.
    >> Share

  21. ZHANG L, Bao LJ, Hong ZD, Yan MX, et al
    Dysregulated Serum Cytokine Production in Pediatric Patients with beta-Thalassemia Major.
    Hemoglobin. 2022;46:191-196.
    >> Share

    May 2022
  22. MANCO L, Santos R, Rocha C, Relvas L, et al
    Hb F Levels in beta-Thalassemia Carriers and Normal Individuals: Known and Unknown Quantitative Trait Loci in the beta-Globin Gene Cluster.
    Hemoglobin. 2022;46:168-175.
    >> Share

  23. REN ZM, Xing ZH, Chen SL, Fu XY, et al
    Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing.
    Hemoglobin. 2022;46:160-163.
    >> Share

  24. KURUCU B, Fettah A, Capkinoglu E, Oner N, et al
    Dynamic Thiol-Disulfide Homeostasis in Children With beta-Thalassemia Trait.
    Hemoglobin. 2022;46:164-167.
    >> Share

  25. KHAMPHIKHAM P, Sakkhachornphop S, Pongsatha S, Pornprasert S, et al
    Strong Positive Dichlorophenolindophenol Precipitation Suggests Hb Dhonburi (or Hb Neapolis) (HBB: c.380T>G) Inheritance in a Couple at Risk for Severe beta-Thalassemia.
    Hemoglobin. 2022;46:184-186.
    >> Share

  26. PARSASEFAT M, Safarpour H, Nomiri S, Miri-Moghaddam E, et al
    Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through CA1 and LIN28B Genes: An In Vitro Study.
    Hemoglobin. 2022;46:153-159.
    >> Share

  27. MORADI K, Aznab M, Azimi A, Biglari M, et al
    alpha-Thalassemia Mutations in Ilam Province, West Iran.
    Hemoglobin. 2022;46:147-152.
    >> Share

    March 2022
  28. VARELAS C, Gavriilaki E, Sakellari I, Klonizakis F, et al
    Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
    Hemoglobin. 2022;46:143-145.
    >> Share

  29. MANGANAS K, Delicou S, Xydaki A, Koskinas J, et al
    Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.
    Hemoglobin. 2022;46:114-117.
    >> Share

  30. ZARKADA E, Yfanti E, Teli A, Balassopoulou A, et al
    Rare Pathogenic beta(0)-Thalassemia Mutation, Codon 7 (GAG>TAG) (HBB: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece.
    Hemoglobin. 2022;46:140-142.
    >> Share

  31. SAHA D, Chowdhury PK, Panja A, Pal D, et al
    Effect of deletions in the alpha-globin gene on the phenotype severity of beta-thalassemia.
    Hemoglobin. 2022;46:118-123.
    >> Share

  32. EFSTATHIOU A, Boutou E, Teli A, Drikos I, et al
    A New Hemoglobin Variant, Hb Natal (HBA1: c.423C>A), Found in a Greek Family.
    Hemoglobin. 2022;46:132-136.
    >> Share

  33. KITTIPOOM T, Tantiworawit A, Punnachet T, Hantrakun N, et al
    The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database.
    Hemoglobin. 2022;46:75-80.
    >> Share

  34. JIANG F, Chen GL, Li J, Tang XW, et al
    beta-Thalassemia Intermedia Caused by the beta-Globin Gene 3' Untranslated Region: Another Case Report.
    Hemoglobin. 2022;46:137-139.
    >> Share

  35. KARAKAYA T, Silan F, Ozdemir O
    A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.
    Hemoglobin. 2022;46:87-90.
    Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.&body=KARAKAYA T, Silan F, Ozdemir O. A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels. Hemoglobin. 2022;46:87-90. https://www.ncbi.nlm.nih.gov/m/pubmed/35930292" ALT="Email" TITLE="Email"> --> >> Share

  36. ZAMAN BA, Ibrahim SA
    Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in beta-Thalassemia Major Patients.
    Hemoglobin. 2022;46:106-113.
    >> Share

  37. BICILIOGLU Y, Bal A, Demir Yenigurbuz F, Ergonul E, et al
    Noninvasive Hemoglobin Measurement Reduce Invasive Procedures in Thalassemia Patients.
    Hemoglobin. 2022;46:95-99.
    >> Share

  38. BINDING A
    Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital.
    Hemoglobin. 2022;46:91-94.
    >> Share

    January 2022
  39. PAIBOONSUKWONG K, Jopang Y, Winichagoon P, Fucharoen S, et al
    Thalassemia in Thailand.
    Hemoglobin. 2022;46:53-57.
    >> Share

  40. CHONG SC, Metassan S, Yusof N, Idros R, et al
    Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam.
    Hemoglobin. 2022;46:15-19.
    >> Share

  41. KHAING AA, Myint PP, Paiboonsukwong K, Win N, et al
    Clinical Severity of beta-Thalassemia Pediatric Patients in Myanmar.
    Hemoglobin. 2022;46:66-70.
    >> Share

  42. COLAH RB, Seth T
    Thalassemia in India.
    Hemoglobin. 2022;46:20-26.
    >> Share

  43. PREMAWARDHENA AP, Madushanka HDP
    Thalassemia in Sri Lanka.
    Hemoglobin. 2022;46:71-73.
    >> Share

  44. CHOWDHURY MA, Sultana R, Das D
    Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh.
    Hemoglobin. 2022;46:7-9.
    >> Share

  45. SOPHAL C
    Thalassemia Status in Cambodia.
    Hemoglobin. 2022;46:10-11.
    >> Share

  46. FUCHAROEN S, Ping C, Paiboonsukwong K
    Introduction to the Special Issue.
    Hemoglobin. 2022;46:1.
    >> Share

  47. KHALIQ S
    Thalassemia in Pakistan.
    Hemoglobin. 2022;46:12-14.
    >> Share

  48. YUSON ED, Naranjo MLT
    Thalassemia in the Philippines.
    Hemoglobin. 2022;46:36-38.
    >> Share

  49. WAHIDIYAT PA, Sari TT, Rahmartani LD, Iskandar SD, et al
    Thalassemia in Indonesia.
    Hemoglobin. 2022;46:39-44.
    >> Share

  50. PHENGSAVANH A, Sengchanh S, Souksakhone C, Souvanlasy B, et al
    Current Status of Thalassemia in Lao People's Democratic Republic.
    Hemoglobin. 2022;46:58-61.
    >> Share

  51. BACH KQ, Nguyen HTT, Nguyen TH, Nguyen MB, et al
    Thalassemia in Viet Nam.
    Hemoglobin. 2022;46:62-65.
    >> Share

  52. ALWI ZB, Syed-Hassan SR
    Thalassemia in Malaysia.
    Hemoglobin. 2022;46:45-52.
    >> Share

  53. CHEN P, Lin WX, Li SQ
    THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.
    Hemoglobin. 2022;46:33-35.
    >> Share

  54. ANURATHAPAN U, Pakakasama S, Songdej D, Pongphitcha P, et al
    Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
    Hemoglobin. 2022;46:2-6.
    >> Share

  55. YADAV SS, Panchal P, Menon KC
    Prevalence and Management of beta-Thalassemia in India.
    Hemoglobin. 2022;46:27-32.
    >> Share

    November 2021
  56. MELVIN RG, Liederman Z, Arya S, Rotin L, et al
    A Case of Fat Embolism Syndrome with Cerebral Involvement in Sickle Cell Anemia.
    Hemoglobin. 2021 Nov 8:1-5. doi: 10.1080/03630269.2021.1990081.
    >> Share

  57. DEHURY S, Mohanty PK, Patel S, Meher S, et al
    Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with alpha-Thalassemia and beta-Globin Gene Cluster Haplotypes from Odisha, India.
    Hemoglobin. 2021;45:380-386.
    >> Share

  58. CHAN NCN, Wong THY, Cheng KCK, Chan NPH, et al
    An Evaluation for the Causes of Reduced Hb A2 and the Molecular Characterization of HBD Variants in Hong Kong.
    Hemoglobin. 2021;45:387-391.
    >> Share

  59. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
    Hemoglobin. 2021;45:371-379.
    >> Share

  60. FARRA C, Abdouni L, Souaid M, Awwad J, et al
    The Spectrum of beta-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study.
    Hemoglobin. 2021;45:365-370.
    >> Share

  61. TSITSIKAS DA, Kamal M, Braimoh A, Benson S, et al
    Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor.
    Hemoglobin. 2021;45:355-357.
    >> Share

  62. ALIYEVA G, Abdulalimov E, Asadov C, Mammadova T, et al
    First Report of beta-Thalassemia Intermedia in a Patient Compound Heterozygous for -92 (C>T) and Codons 36/37 (-T) Mutations.
    Hemoglobin. 2021;45:347-348.
    >> Share

    September 2021
  63. HUANG LF, Yu LL, Nikuze L, Singh S, et al
    Spectrum of beta-Thalassemia Mutations in Some Areas of Guangxi Zhuang Autonomous Region of Southern China: A Study on a Pediatric Population Aged 0-15 Years.
    Hemoglobin. 2021;45:318-321.
    >> Share

  64. HAMALI HA
    Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia.
    Hemoglobin. 2021;45:287-295.
    >> Share

  65. YADAV DD, Jamwal M, Singh N, Sharma R, et al
    Hb Mizuho (HBB: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing.
    Hemoglobin. 2021;45:338-340.
    >> Share

  66. RUENGDIT C, Punyamung M, Khamphikham P, Pongpunyayuen P, et al
    Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia.
    Hemoglobin. 2021;45:309-313.
    >> Share

  67. TRUTTMANN R, Schmidt A, Hartmann B, Rusch S, et al
    Description of Hb Evora (HBA2: c.106T>C) on an Unexpected Allele in a Swiss Family.
    Hemoglobin. 2021;45:314-317.
    >> Share

  68. ZAHRA A, Ragab A, Al-Abboh H, Ismaiel A, et al
    Perforated Duodenal Ulcer Associated with Deferasirox in a Child with beta-Thalassemia Major.
    Hemoglobin. 2021;45:335-337.
    >> Share

  69. CHEN HQ, Wu LS, Jiang F, Li DZ, et al
    Dominant beta-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.
    Hemoglobin. 2021;45:329-331.
    >> Share

  70. SEN A, Seenappa V, Chakrabarti P, Dolai TK, et al
    First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the beta-Globin Gene in the Indian Population.
    Hemoglobin. 2021;45:325-328.
    >> Share

  71. DELICOU S, Aggeli K, Magganas K, Patsourakos D, et al
    Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital.
    Hemoglobin. 2021;45:303-308.
    >> Share

  72. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    The Prevalence of Hypothyroidism among Patients With beta-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies.
    Hemoglobin. 2021;45:275-286.
    >> Share

  73. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable alpha Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography.
    Hemoglobin. 2021;45:322-324.
    >> Share

  74. TRIPATHY I, Panja A, Dolai TK, Mallick AK, et al
    Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali beta-Thalassemia Major Children.
    Hemoglobin. 2021;45:296-302.
    >> Share

    July 2021
  75. ATROSHI SD, Al-Allawi NAS, Eissa AA
    Updated Molecular Spectrum of beta-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration.
    Hemoglobin. 2021;45:239-244.
    >> Share

  76. PERERA S, Allen A, Rees DC, Premawardhena A, et al
    Pitfalls in the Diagnosis of beta-Thalassemia Intermedia.
    Hemoglobin. 2021;45:265-268.
    >> Share

  77. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study.
    Hemoglobin. 2021;45:256-258.
    >> Share

  78. ETEMAD K, Mohseni P, Aghighi M, Bahadorimonfared A, et al
    Quality of Life and Related Factors in beta-Thalassemia Patients.
    Hemoglobin. 2021;45:245-249.
    >> Share

  79. UCUCU S, Karabiyik T, Azik FM
    IVS-II-16 (G>C) (HBB: c.315+16G>C) or IVS-II-666 (C>T) (HBB: c.316-185C>T) Mutations Trigger an Hb S (HBB: c.20A>T)/beta(+)-Thalassemia Phenotype in an Hb S Trait Patient.
    Hemoglobin. 2021;45:225-227.
    >> Share

  80. IDRIS IM, Yusuf AA, Gwarzo DH, Kurawa MS, et al
    High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy.
    Hemoglobin. 2021;45:228-233.
    >> Share

  81. MARTIN G, Grimholt RM, Le D, Bechensteen AG, et al
    Hb Calgary (HBB: c.194G>T): A Highly Unstable Hemoglobin Variant with a beta-Thalassemia Major Phenotype.
    Hemoglobin. 2021;45:215-219.
    >> Share

  82. RAFAT M, Allamehzadeh Z, Shekari M, Afsa M, et al
    The Effect of HBB: c.-121C>T Variant [-71 (C>T)] on the beta-Globin Promoter: Case Series Study.
    Hemoglobin. 2021;45:234-238.
    >> Share

  83. JIANG F, Tang XW, Li J, Zhou JY, et al
    Hb Lepore-Hong Kong: First Report of a Novel delta/beta-Globin Gene Fusion in a Chinese Family.
    Hemoglobin. 2021;45:220-224.
    >> Share

    June 2021
  84. ANAH MU, Nlemadim AC, Uzomba CI, Ineji EO, et al
    Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia.
    Hemoglobin. 2021 Jun 10:1-6. doi: 10.1080/03630269.2021.1937207.
    >> Share

    May 2021
  85. ZHAO Q, Zhao SM, Zhang X, Chen SP, et al
    Detection of the HBB: c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia.
    Hemoglobin. 2021 May 25:1-4. doi: 10.1080/03630269.2021.1929307.
    >> Share

  86. BROWN BJ, Madu A, Sangeda RZ, Nkya S, et al
    Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
    Hemoglobin. 2021;45:163-170.
    >> Share

  87. TSOLAKIDIS V, Vlachaki E, Papaioannou M, Pantelidou D, et al
    Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece.
    Hemoglobin. 2021;45:143-149.
    >> Share

  88. MOORE JA, Pullon BM, Wang D, Brennan SO, et al
    Hb Tacoma: G>T or G>C, and Does It Matter?
    Hemoglobin. 2021;45:203-206.
    >> Share

  89. SOOD R, Rastogi P, Bansal D, Das R, et al
    An Autopsy Case of beta-Thalassemia Major Illuminating the Pathological Spectrum of the Disease.
    Hemoglobin. 2021;45:180-185.
    >> Share

  90. ATROSHI SD, Al-Allawi N, Chui DHK, Najmabadi H, et al
    A Novel beta(0)-Thalassemia Mutation, HBB: c.356_357delTT [Codon 118 (-TT)] in an Iraqi Kurd.
    Hemoglobin. 2021;45:212-214.
    >> Share

  91. SAENSUWANNA A, Penglong T, Srinoun K
    Upregulation of miR-214 Mediates Oxidative Stress in Hb H Disease via Targeting of ATF4.
    Hemoglobin. 2021;45:197-202.
    >> Share

  92. RUJEERAPAIBOON N, Tantiworawit A, Piriyakhuntorn P, Rattanathammethee T, et al
    Correlation Between Serum Ferritin and Viral Hepatitis in Thalassemia Patients.
    Hemoglobin. 2021;45:175-179.
    >> Share

  93. THEPPORNPITAK K, Trakarnsanga B, Lauhasurayotin S, Poparn H, et al
    A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients.
    Hemoglobin. 2021;45:171-174.
    >> Share

  94. LUO LP, Ma L, Lin SB, Huang JG, et al
    Elevated Hb A2 is Not Always Indicative of beta-Thalassemia.
    Hemoglobin. 2021;45:186-190.
    >> Share

  95. SAHA J, Panja A, Nayek K
    The Prevalence of HBB Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/beta-Thalassemia Children in a Tertiary Center of West Bengal, India.
    Hemoglobin. 2021;45:157-162.
    >> Share

  96. TIAN Q, Lei YL, Xu LL, Li DZ, et al
    First Report of Nondeletional Hb H Disease Caused by an alpha2-Globin Gene Mutation: HBA2: c.184A>T.
    Hemoglobin. 2021;45:210-211.
    >> Share

    March 2021
  97. ALIMOHAMMADI-BIDHENDI S, Azadmehr S, Razipour M, Zeinali S, et al
    Regulatory Mutation Study in Cases with Unsolved Hypochromic Microcytic Anemia and alpha-Major Regulatory Element Haplotype Analysis in Iran.
    Hemoglobin. 2021 Mar 27:1-4. doi: 10.1080/03630269.2021.1882482.
    >> Share

  98. OGU UO, Reyes Gil M, Tolu SS, Acharya SA, et al
    First Report of Compound Heterozygosity for Hb S (HBB: c.20A>T) and Hb Haringey (HBB: c.131A>G).
    Hemoglobin. 2021;45:136-139.
    >> Share

  99. YIN Z, Hao Y, Huang X, Chen X, et al
    A Novel Mutation at HBA1: c.349G>T Causing alpha-Thalassemia in a Chinese Family.
    Hemoglobin. 2021;45:94-96.
    >> Share

  100. MARTINEZ VILLEGAS O, Mendoza-Melendez D, Trueba-Gomez R, Rosenfeld-Mann F, et al
    Analysis of a Novel Mexican Variant of the HBB Gene Associated with beta-Thalassemia Using Bioinformatic Tools.
    Hemoglobin. 2021;45:87-93.
    >> Share

  101. INATI A, Al Alam C, El Ojaimi C, Hamad T, et al
    Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry.
    Hemoglobin. 2021;45:80-86.
    >> Share

  102. PANICHCHOB P, Iamdeelert P, Wongsariya P, Wongsariya P, et al
    Molecular Spectrum of beta-Thalassemia Mutations in Central to Eastern Thailand.
    Hemoglobin. 2021;45:97-102.
    >> Share

  103. SHARIFI F, Safizadeh H, Bahrampour A
    Development of the Quality of Life Questionnaire (SF-36) for Patients with beta-Thalassemia Major and beta-Thalassemia Intermedia Based on Extended Rasch Analysis.
    Hemoglobin. 2021;45:119-123.
    >> Share

  104. ZARDKHONI SZ, Moghaddam AG, Rad F, Ghatee MA, et al
    Serum Zinc Level in beta-Thalassemia Major: A Retrospective Study in Southwest Iran.
    Hemoglobin. 2021;45:103-106.
    >> Share

  105. ZHAO YL, Lin QF, He XW, Li YQ, et al
    Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.
    Hemoglobin. 2021;45:133-135.
    Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.&body=ZHAO YL, Lin QF, He XW, Li YQ, et al. Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene. Hemoglobin. 2021;45:133-135. https://www.ncbi.nlm.nih.gov/m/pubmed/33843396" ALT="Email" TITLE="Email"> --> >> Share

  106. SOLTANI D, Fakhrzadeh H, Sharifi F, Mahmoudi MJ, et al
    Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with beta-Thalassemia Major.
    Hemoglobin. 2021;45:107-111.
    >> Share

  107. COLAH RB, Nadkarni AH, Gorakshakar AC, Sawant PM, et al
    The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades.
    Hemoglobin. 2021;45:112-118.
    >> Share

  108. RUENGDIT C, Khamphikham P, Jinorose N, Pornprasert S, et al
    Hb Bart's Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (- -(CR)) alpha(0)-Thalassemia in Two Unrelated Thai Families.
    Hemoglobin. 2021;45:75-79.
    >> Share

  109. WANG RY, Jiang F, Xu LL, Li DZ, et al
    Mild alpha-Thalassemia Caused by a Mosaic alpha-Globin Gene Mutation.
    Hemoglobin. 2021;45:140-141.
    >> Share

    January 2021
  110. MEHER S, Mohanty PK, Patel S, Das K, et al
    Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
    Hemoglobin. 2021 Jan 3:1-7. doi: 10.1080/03630269.2020.1801459.
    >> Share

  111. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
    beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
    Hemoglobin. 2021;45:1-4.
    >> Share

  112. CHEN X, Lin Z, Hu J, Chen S, et al
    Report of Two Novel Thalassemia Variants, HBB: c.181delG and HBA1: c.121_126delAAGACC, in Chinese Individuals.
    Hemoglobin. 2021;45:52-55.
    >> Share

  113. LIU L, Sun Y, Chen S, Yu C, et al
    Identification of Two Novel Thalassemia Variants, HBA1: c.263delA and HBA2: c.376dupC, in Chinese Individuals.
    Hemoglobin. 2021;45:49-51.
    >> Share

  114. AL-ZUHAIRY SH, Darweesh MA, Othman MA
    Relation of Serum Ferritin Level with Serum Hepcidin and Fucose Levels in Children with beta-Thalassemia Major.
    Hemoglobin. 2021;45:69-73.
    >> Share

  115. BALLAS SK, Riddick-Burden G, Congdon-Martin E
    Determinants of the Outcome of the Transition of Children with Sickle Cell Disease to Adult Programs.
    Hemoglobin. 2021;45:62-65.
    >> Share

  116. TARIQ A, Khurshid S, Sajjad M
    Evaluation of the High Resolution Melting Approach for Detection of beta-Thalassemia Gene Mutations.
    Hemoglobin. 2021;45:20-24.
    >> Share

  117. LIN QY, Chen DY, Kong S, Liu WQ, et al
    A Rare Case of Hb H Disease and Systemic Lupus Erythematosus.
    Hemoglobin. 2021;45:66-68.
    >> Share

  118. WANG WJ, Ding ZX, Zhang HM, Tao TT, et al
    Identification of a Novel beta-Thalassemia Mutation at Codon 130 (+T) (HBB: c.391insT) in Han Chinese.
    Hemoglobin. 2021;45:46-48.
    >> Share

  119. GOLLAMUDI J, Sarvepalli S, Vadaparti Binf A, Alin T, et al
    Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia.
    Hemoglobin. 2021;45:56-59.
    >> Share

  120. SIGAL IR, Ciunci CA
    Case Report of Acute Splenic Sequestration Crisis in an Adult Patient with Hb S Disease and Suspected Hereditary Persistence of Fetal Hemoglobin.
    Hemoglobin. 2021;45:60-61.
    >> Share

  121. DOULGERAKI A, Fragodimitri C, Athanasopoulou H, Drakaki K, et al
    Chronic Hemolysis May Adversely Affect Skeletal Health. A Cross-Sectional Study of a Pediatric Population.
    Hemoglobin. 2021;45:30-36.
    >> Share

  122. AYDOGDU S, Toret E, Aksoy BA, Aydin MF, et al
    Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with beta-Thalassemia Major from Three Different Graft Types.
    Hemoglobin. 2021;45:25-29.
    >> Share

  123. ANGASTINIOTIS M, Petrou M, Loukopoulos D, Modell B, et al
    The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation.
    Hemoglobin. 2021;45:5-12.
    >> Share

  124. LIEDERMAN Z, Quartey NK, Ward R, Papadakos J, et al
    Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient-Physician Partnerships to Improve Care.
    Hemoglobin. 2021;45:13-19.
    >> Share

    November 2020
  125. CHOURASIA S, Kumar R, Singh MPSS, Vishwakarma C, et al
    High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Hemoglobin. 2020 Nov 22:1-10. doi: 10.1080/03630269.2020.1848859.
    >> Share

    July 2020
  126. BALANCHIVADZE N, Kudirka AA, Askar S, Almadhoun K, et al
    Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Hemoglobin. 2020;44:284-289.
    >> Share

    March 2020
  127. TERAN MM, Monaco ME, Lazarte SS, Haro C, et al
    Genetic Regulation of Redox Balance in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:122-127.
    >> Share

  128. AL-ALI AK, Alsulaiman A, Alzahrani AJ, Obeid OT, et al
    Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.
    Hemoglobin. 2020;44:78-81.
    >> Share

  129. AZIMI A, Tahmasebi S, Moradi K, Nejati P, et al
    Severe alpha-Thalassemia Due to Compound Heterozygosity for Hb Adana (alpha59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
    Hemoglobin. 2020;44:139-142.
    >> Share

  130. HORRI-NACEUR A, Timson DJ
    In Silico Analysis of the Effects of Point Mutations on alpha-Globin: Implications for alpha-Thalassemia.
    Hemoglobin. 2020;44:89-103.
    >> Share

  131. SAMHA L, Sirdah MM, Reading NS, Karmi B, et al
    Molecular Understanding of Severe Cases of beta-Thalassemia in the Nablus Region, West Bank, Palestine.
    Hemoglobin. 2020;44:128-130.
    >> Share

  132. AKSU T, Coskun C, Kuskonmaz B, Unal S, et al
    Hb H Disease Diagnosed During Adolescent Pregnancy.
    Hemoglobin. 2020;44:137-138.
    >> Share

  133. AZARKEIVAN A, Cohan N, Niazkar HR, Azizi A, et al
    Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
    Hemoglobin. 2020;44:109-112.
    >> Share

  134. HALDER R, Sundaram UKD, Veetil KK, Rath A, et al
    Concomitant Existence of Paroxysmal Nocturnal Hemoglobinuria in a Patient with Hb E (HBB: c.79G>A) Trait.
    Hemoglobin. 2020;44:134-136.
    >> Share

  135. JIANG F, Xu LL, Chen GL, Zhou JY, et al
    Hematological Characteristics of Hb Constant Spring (HBA2: c.427T>C) Carriers in Mainland China.
    Hemoglobin. 2020;44:86-88.
    >> Share

  136. MANCO L, Bento C, Relvas L, Cunha E, et al
    Multi-Locus Models to Address Hb F Variability in Portuguese beta-Thalassemia Carriers.
    Hemoglobin. 2020;44:113-117.
    >> Share

  137. AL-NOOD HA, Al-Nood RM, Ghanem NS, Al-Hadi AM, et al
    Effect of the Hydoxyurea in Yemeni Transfusion-Dependent beta-Thalassemia Patients.
    Hemoglobin. 2020;44:104-108.
    >> Share

  138. ALASHKAR F, Herbstreit F, Carpinteiro A, Baum J, et al
    Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
    Hemoglobin. 2020;44:71-77.
    >> Share

  139. CHEN YJ, Li YQ, Liu Q, Tang LY, et al
    A Chinese Male with Normal Hematological Indices and High Hb A2 Levels in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:131-133.
    >> Share

    January 2020
  140. SARIHI R, Amirizadeh N, Oodi A, Azarkeivan A, et al
    Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent beta-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
    Hemoglobin. 2020;44:31-36.
    >> Share

  141. BELISARIO AR, Carneiro-Proietti AB, Sabino EC, Araujo A, et al
    Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
    Hemoglobin. 2020;44:1-9.
    >> Share

  142. MASHON RS, Das R, Dhawan R, Kakkar N, et al
    Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
    Hemoglobin. 2020;44:64-66.
    >> Share

  143. MIR SA, Alshehri BM, Alaidarous M, Banawas SS, et al
    Prevalence of Hemoglobinopathies (beta-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
    Hemoglobin. 2020;44:47-50.
    >> Share

  144. NAZ S, Rehman SU, Shakeel M, Rehman H, et al
    Molecular Heterogeneity of beta-Thalassemia in the Kohat Region, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2020;44:37-41.
    >> Share

  145. AL-RIYAMI AZ, Daar S, Kindi SA, Madhani AA, et al
    alpha-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
    Hemoglobin. 2020;44:20-26.
    >> Share

  146. ROPERO P, Arbeteta J, Nieto JM, Gonzalez FA, et al
    Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene.
    Hemoglobin. 2020;44:17-19.
    >> Share

  147. VAN GAMMEREN AJ, Pelkmans L, Endschot CCWV, Roelofsen-de Beer RJAC, et al
    An Unusual Compound Heterozygosity for Hb O-Arab (HBB: c.364G>A) and Hb D-Los Angeles (HBB: c.364G>C).
    Hemoglobin. 2020;44:61-63.
    >> Share

  148. LUO H, Zou Y, Liu Y
    A Novel beta-Thalassemia Mutation [IVS-I-6 (T>G), HBB: c.92+6T>G] in a Chinese Family.
    Hemoglobin. 2020;44:55-57.
    >> Share

  149. CHEN X, Luo S, Huang J, Yuan D, et al
    Diagnosis and Prenatal Diagnosis in a Chinese Family Carrying the Rare alpha-Thalassemia Gene HBA2: c.1A>G Mutation.
    Hemoglobin. 2020;44:51-54.
    >> Share

  150. SAKAMOTO A, Nakadate H, Tada K, Yamashiro Y, et al
    A Japanese Family with the Unstable Hb Sydney (HBB: c.203T>C) Variant and Persistent Low Hemoglobin Oxygen Saturation.
    Hemoglobin. 2020;44:58-60.
    >> Share

  151. SHOUJAA A, Moasses F, Mukhalalaty Y, Murad H, et al
    Genotype/Phenotype Correlation of beta-Thalassemia in Syrian Patients: A Cross-Sectional Study.
    Hemoglobin. 2020;44:42-46.
    >> Share

  152. SAJADPOUR Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, et al
    Association between Different Polymorphic Markers and beta-Thalassemia Intermedia in Central Iran.
    Hemoglobin. 2020;44:27-30.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016